Tat-OH

General Information


DRACP ID  DRACP05707

Peptide Name   Tat-OH

Sequence  YGRKKRRQRRRX

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=acp, Epsilon-aminocaproic acid

Chiral  L



Physicochemical Information


Formula  C64H116N32O13

Absent amino acids  ACDEFHILMNPSTVW

Common amino acids  R

Mass  184819

Pl  12.81

Basic residues  8

Acidic residues  0

Hydrophobic residues  0

Net charge  8

Boman Index  -10536

Hydrophobicity  -333.33

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  135.45

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23085023

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2766

DRACP is developed by Dr.Zheng's team.